poisar

Stocks · News reference

Aclaris Therapeutics Initiates Phase 2b Trial of Modzatinib in Lichen Planus

Fiscal.ai

Aclaris Therapeutics has commenced a Phase 2b clinical trial for its treatment candidate, modzatinib, targeting lichen planus.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading